237 related articles for article (PubMed ID: 24089559)
1. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
2. Temporary upregulation of anti-inflammatory cytokine IL-13 expression in the brains of CD14 deficient mice in the early stage of prion infection.
Hasebe R; Suzuki A; Yamasaki T; Horiuchi M
Biochem Biophys Res Commun; 2014 Nov; 454(1):125-30. PubMed ID: 25450368
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory response of microglia to prions is controlled by sialylation of PrP
Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
[TBL] [Abstract][Full Text] [Related]
4. Complement 3
Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
[TBL] [Abstract][Full Text] [Related]
5. Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K.
Xie WL; Shi Q; Zhang J; Zhang BY; Gong HS; Guo Y; Wang SB; Xu Y; Wang K; Chen C; Liu Y; Dong XP
J Mol Neurosci; 2013 Nov; 51(3):919-32. PubMed ID: 23526370
[TBL] [Abstract][Full Text] [Related]
6. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
8. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.
Hughes MM; Field RH; Perry VH; Murray CL; Cunningham C
Glia; 2010 Dec; 58(16):2017-30. PubMed ID: 20878768
[TBL] [Abstract][Full Text] [Related]
9. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
[TBL] [Abstract][Full Text] [Related]
10. Glimepiride reduces CD14 expression and cytokine secretion from macrophages.
Ingham V; Williams A; Bate C
J Neuroinflammation; 2014 Jun; 11():115. PubMed ID: 24952384
[TBL] [Abstract][Full Text] [Related]
11. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.
Riemer C; Schultz J; Burwinkel M; Schwarz A; Mok SW; Gültner S; Bamme T; Norley S; van Landeghem F; Lu B; Gerard C; Baier M
J Virol; 2008 Dec; 82(24):12464-71. PubMed ID: 18842729
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin-1 in prion disease-associated astrocyte activation.
Schultz J; Schwarz A; Neidhold S; Burwinkel M; Riemer C; Simon D; Kopf M; Otto M; Baier M
Am J Pathol; 2004 Aug; 165(2):671-8. PubMed ID: 15277240
[TBL] [Abstract][Full Text] [Related]
13. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
[TBL] [Abstract][Full Text] [Related]
14. Outbred ICR/CD1 mice display more severe neuroinflammation mediated by microglial TLR4/CD14 activation than inbred C57Bl/6 mice.
Nikodemova M; Watters JJ
Neuroscience; 2011 Sep; 190():67-74. PubMed ID: 21683771
[TBL] [Abstract][Full Text] [Related]
15. A neuroprotective role for microglia in prion diseases.
Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia.
Chang J; Yang L; Kouadir M; Peng Y; Zhang S; Shi F; Zhou X; Yin X; Zhao D
J Mol Neurosci; 2012 Sep; 48(1):248-52. PubMed ID: 22648512
[TBL] [Abstract][Full Text] [Related]
17. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
[TBL] [Abstract][Full Text] [Related]
18. Accelerated prion disease in the absence of interleukin-10.
Thackray AM; McKenzie AN; Klein MA; Lauder A; Bujdoso R
J Virol; 2004 Dec; 78(24):13697-707. PubMed ID: 15564479
[TBL] [Abstract][Full Text] [Related]
19. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
20. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.
Tribouillard-Tanvier D; Striebel JF; Peterson KE; Chesebro B
J Virol; 2009 Nov; 83(21):11244-53. PubMed ID: 19710140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
